bluebird bio (BLUE) Reports Strategic Collaboration with TC BioPharm to Research and Develop Gamma Delta CAR T … – StreetInsider.com
Endpoints News |
bluebird bio (BLUE) Reports Strategic Collaboration with TC BioPharm to Research and Develop Gamma Delta CAR T …
StreetInsider.com bluebird bio, Inc. (NASDAQ: BLUE) and Scottish immunotherapy company TC BioPharm, Ltd. (TCB) today announced a strategic collaboration and license agreement focused on gamma delta CAR T cells. The companies will work together to advance TC BioPharm's … Taking on gamma delta T cells, bluebird pays $16M for TC BioPharm's tumor invading tech platform TC BioPharm teams up with bluebird bio to develop gamma delta CAR Ts Fate Therapeutics and University of California San Diego Launch Research Collaboration to Develop iPSC-Derived … |
